跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clavasul - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clavasul
Approved
STANDARD
Clavasul
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bf7671a970c88dbd
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
bf7671a970c88dbd
Drug Approval Philippines Name
Clavasul
Product Name
Clavasul
Registration Number
DRP-615-15
Brand Name
Clavasul
Generic Name
Co-Amoxiclav
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg/125 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Gamot Philippines, Inc.
Distributor
Medilyn Drug
Issuance Date
28 February 2022
Expiry Date
02 April 2027
Pharmacologic Category
Antibacterial (Penicillin + Beta-Lactamase Inhibitor Combination)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bf7671a970c88dbd
Type
Standard
Back to Philippines FDA Approvals